Symptoms mirror Omicron’s, that is, fever, cough, fatigue, sore throat, and muscle aches. Though India’s Covid response ...

A Wall Street maxim states, “Twenty percent of investors who want to make money are in stocks, while the other 80 percent who ...

A widely available antiviral medication offers new possibilities for long Covid patients seeking relief from debilitating ...

A meta-analysis of 187 trials shows that Paxlovid and remdesivir reduce the risk for hospitalization in patients with mild-to ...

Encounter-level factors played a key role in limiting outpatient COVID-19 treatment for Black and Latino patients.

Scientists are currently studying how well people are protected against severe disease from XFG. Researchers conducted lab ...

Paxlovid™ is an antiviral drug developed by Pfizer under the generic name combination of ritonavir and nirmatrelvir, the former and latter of which are highly effective in treating COVID-19.

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions ...

PFE trades above its 50-day average for over a month, signaling bullish momentum despite COVID revenue declines and patent ...

Three supercharged dividend stocks have the necessary catalysts to make their patient shareholders notably richer.

Phase 2 protocol submitted to HREC to evaluate tivoxavir marboxil (TXM) in a combined seasonal and bird flu study in the Southern Hemisphere Briefing documents submitted to FDA for a Type D meeting ...